{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "atorvastatin", "pneumonia", "treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35274326", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "20"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1002/jmv.27710"], "Journal": {"ISSN": "1096-9071", "JournalIssue": {"Volume": "94", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Jul"}}, "Title": "Journal of medical virology", "ISOAbbreviation": "J Med Virol"}, "ArticleTitle": "Survival of the hospitalized patients with COVID-19 receiving atorvastatin: A randomized clinical trial.", "Pagination": {"StartPage": "3160", "EndPage": "3168", "MedlinePgn": "3160-3168"}, "Abstract": {"AbstractText": ["As statins decrease the progression of sepsis and its related mortality, this study aimed to evaluate the effect of atorvastatin on survival and symptom improvement in hospitalized patients with COVID-19. This randomized controlled trial was performed on 156 hospitalized patients with COVID-19 in Bojnourd city in 2021. Patients were randomly divided into comparison (standard therapy: hydroxychloroquine + Kaletra\u00ae) and intervention groups (atorvastatin 20\u2009mg, SD, plus standard therapy). The main outcomes were the rate of symptom improvement, duration of hospitalization, need for intubation, and mortality rate. In this study, seven patients died, two patients (2.6%) in the comparison group and five (6.6%) in the intervention group. The mean hospitalization days (p\u2009=\u20090.001), the pulse rate (p\u2009=\u20090.004), and the frequency of hospitalization in the ICU ward (18.4% vs. 1.3%) were longer and greater in the intervention group. The remission probability in the comparison group was greater (p\u2009=\u20090.0001). The median hospitalization days in the intervention group was longer (p\u2009<\u20090.001) and remission in the comparison group occurred 1.71 times sooner (hazard ratio\u2009=\u20091.70, 95% confidence interval\u2009=\u20091.22-2.38, p\u2009=\u20090.002). Totally, adding atorvastatin to the standard regime in this study increased hospitalization days and imposed negative effects on symptom improvement in hospitalized patients with COVID-19."], "CopyrightInformation": "\u00a9 2022 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious Diseases, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Ghafoori", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Department of Epidemiology and Biostatistics, School of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Saadati", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious Diseases, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Taghavi", "ForeName": "Mohammadreza", "Initials": "M"}, {"Identifier": ["0000-0002-2532-8198"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Azimian", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Alesheikh", "ForeName": "Peiman", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology and Medical Physics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mohajerzadeh", "ForeName": "Mina Sadat", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Behnamfar", "ForeName": "Morteza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Imam Hassan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Pakzad", "ForeName": "Marzieh", "Initials": "M"}, {"Identifier": ["0000-0001-6822-8552"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Rameshrad", "ForeName": "Maryam", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Virol", "NlmUniqueID": "7705876", "ISSNLinking": "0146-6615"}, "ChemicalList": [{"RegistryNumber": "4QWG6N8QKH", "NameOfSubstance": "Hydroxychloroquine"}, {"RegistryNumber": "A0JWA85V8F", "NameOfSubstance": "Atorvastatin"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Atorvastatin"}, {"QualifierName": [], "DescriptorName": "Hospitalization"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hydroxychloroquine"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u2010733.", "ArticleIdList": ["PMC7092803", "31978945"]}, {"Citation": "Hu B, Huang S, Yin L. The cytokine storm and COVID\u201019. J Med Virol. 2021;93(1):250\u2010256.", "ArticleIdList": ["PMC7361342", "32592501"]}, {"Citation": "Bikbov B, Bikbov A. Maximum incubation period for COVID\u201019 infection: do we need to rethink the 14\u2010day quarantine policy? Travel Med Infect Dis. 2021;40:101976.", "ArticleIdList": ["PMC7816956", "33476809"]}, {"Citation": "Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019\u2010nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382(10):970\u2010971.", "ArticleIdList": ["PMC7120970", "32003551"]}, {"Citation": "Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2010506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Bassetti M, Vena A, Giacobbe DR. The novel Chinese coronavirus (2019\u2010nCoV) infections: challenges for fighting the storm. Eur J Clin Invest. 2020;50(3):e13209.", "ArticleIdList": ["PMC7163647", "32003000"]}, {"Citation": "Rameshrad M, Ghafoori M, Mohammadpour AH, Nayeri M, Hosseinzadeh H. A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19). Naunyn Schmiedebergs Arch Pharmacol. 2020;393(7):1137\u20101152.", "ArticleIdList": ["PMC7235439", "32430617"]}, {"Citation": "\nBeware of Fraudulent Coronavirus Tests, Vaccines and Treatments\n. 2021. https://www.fda.gov/consumers/consumer-updates/beware-fraudulent-coronavirus-tests-vaccines-and-treatments."}, {"Citation": "\nDrug and Biological Therapeutic Products\n. 2021.\u00a0https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs\n"}, {"Citation": "\nFlowchart Diagnosis and Treatment of COVID 19 Disease at Outpatient and Inpatient Levels\n, 6th edition. 2020. https://medcare.behdasht.gov.ir/uploads/%D9%86%D8%B3%D8%AE%D9%87_%D8%B4%D8%B4%D9%85_%D9%81%D9%84%D9%88%DA%86%D8%A7%D8%B1%D8%AA.pdf\n"}, {"Citation": "Kwak BR, Mulhaupt F, Mach F. Atherosclerosis: anti\u2010inflammatory and immunomodulatory activities of statins. Autoimmun Rev. 2003;2(6):332\u2010338.", "ArticleIdList": ["14550874"]}, {"Citation": "Kim SW, Kang HJ, Jhon M, et al. Statins and inflammation: new therapeutic opportunities in psychiatry. Front Psychiatry. 2019;10:103.", "ArticleIdList": ["PMC6413672", "30890971"]}, {"Citation": "Mayer C, Gruber HJ, Landl EM, et al. Rosuvastatin reduces interleukin\u20106\u2010induced expression of C\u2010reactive protein in human hepatocytes in a STAT3\u2010 and C/EBP\u2010dependent fashion. Int J Clin Pharmacol Ther. 2007;45(6):319\u2010327.", "ArticleIdList": ["17595889"]}, {"Citation": "Garjani A, Rezazadeh H, Andalib S, et al. Ambivalent effects of atorvastatin on angiogenesis, epidermal cell proliferation and tumorgenesis in animal models. Iran Biomed J. 2012;16(2):59\u201067.", "ArticleIdList": ["PMC3600953", "22801278"]}, {"Citation": "Link A, Ayadhi T, B\u00f6hm M, Nickenig G. Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome. Eur Heart J. 2006;27(24):2945\u20102955.", "ArticleIdList": ["17012299"]}, {"Citation": "Dutta NK, Bruiners N, Zimmerman MD, et al. Adjunctive host\u2010directed therapy with statins improves tuberculosis\u2010related outcomes in mice. J Infect Dis. 2020;221(7):1079\u20101087.", "ArticleIdList": ["PMC7325721", "31605489"]}, {"Citation": "Elahi S, Weiss RH, Merani S. Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. AIDS. 2016;30(2):171\u2010183.", "ArticleIdList": ["26645604"]}, {"Citation": "Gower TL, Graham BS. Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob Agents Chemother. 2001;45(4):1231\u20101237.", "ArticleIdList": ["PMC90448", "11257039"]}, {"Citation": "Blanc M, Hsieh WY, Robertson KA, et al. Host defense against viral infection involves interferon mediated down\u2010regulation of sterol biosynthesis. PLOS Biol. 2011;9(3):e1000598.", "ArticleIdList": ["PMC3050939", "21408089"]}, {"Citation": "Sapey E, Patel JM, Greenwood H, et al. Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial. Am J Respir Crit Care Med. 2019;200(10):1282\u20101293.", "ArticleIdList": ["PMC6857486", "31206313"]}, {"Citation": "Stamatogiannis N, Makris D, Zakynthinos E. Statins in bacteremia, sepsis and pneumonia: have we found the holy grail. Recent Pat Inflamm Allergy Drug Discov. 2009;3(3):167\u2010176.", "ArticleIdList": ["19663775"]}, {"Citation": "Henry C, Zaizafoun M, Stock E, Ghamande S, Arroliga AC, White HD. Impact of angiotensin\u2010converting enzyme inhibitors and statins on viral pneumonia. Proc (Bayl Univ Med Cent). 2018;31(4):419\u2010423.", "ArticleIdList": ["PMC6414001", "30948970"]}, {"Citation": "Mach F, Baigent C, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41(1):111\u2010188.", "ArticleIdList": ["31504418"]}, {"Citation": "Ayeh SK, Abbey EJ, Khalifa BAA, et al. Statins use and COVID\u201019 outcomes in hospitalized patients. PLOS One. 2021;16(9):e0256899.", "ArticleIdList": ["PMC8432819", "34506533"]}, {"Citation": "Cariou B, Goronflot T, Rimbert A, et al. Routine use of statins and increased COVID\u201019 related mortality in inpatients with type 2 diabetes: results from the CORONADO study. Diabetes Metab. 2021;47(2):101202.", "ArticleIdList": ["PMC7572108", "33091555"]}, {"Citation": "Peymani P, Dehesh T, Aligolighasemabadi F, et al. Statins in patients with COVID\u201019: a retrospective cohort study in Iranian COVID\u201019 patients. Transl Med Commun. 2021;6(1):3.", "ArticleIdList": ["PMC7829327", "33521322"]}, {"Citation": "Bikdeli B, Talasaz AH, Sharif\u2010Kashani B, et al. Atorvastatin versus placebo in patients with covid\u201019 in intensive care: randomized controlled trial. BMJ. 2022;376:e068407.", "ArticleIdList": ["34996756"]}, {"Citation": "Davoodi L, Jafarpour H, Oladi Z, et al. Atorvastatin therapy in COVID\u201019 adult inpatients: a double\u2010blind, randomized controlled trial. IJC Heart Vasc. 2021;36:100875.", "ArticleIdList": ["PMC8437805", "34541293"]}, {"Citation": "De Spiegeleer A, Bronselaer A, Teo JT, et al. The effects of ARBs, ACEis, and statins on clinical outcomes of COVID\u201019 infection among nursing home residents. J Am Med Dir Assoc. 2020;21(7):909\u2010914.", "ArticleIdList": ["PMC7294267", "32674818"]}, {"Citation": "Daniels LB, Sitapati AM, Zhang J, et al. Relation of statin use prior to admission to severity and recovery among COVID\u201019 inpatients. Am J Cardiol. 2020;136:149\u2010155.", "ArticleIdList": ["PMC7492151", "32946859"]}, {"Citation": "Gupta A, Madhavan MV, Poterucha TJ. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID\u201019. Res Sq. 2020:rs.3.rs\u201056210.", "ArticleIdList": ["PMC7910606", "33637713"]}, {"Citation": "Shyamsundar M, McKeown ST, O'Kane CM, et al. Simvastatin decreases lipopolysaccharide\u2010induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med. 2009;179(12):1107\u20101114.", "ArticleIdList": ["PMC2695496", "19324974"]}, {"Citation": "Santos RA, Ferreira AJ, Sim\u00f5es ESAC. Recent advances in the angiotensin\u2010converting enzyme 2\u2010angiotensin(1\u20107)\u2010Mas axis. Exp Physiol. 2008;93(5):519\u2010527.", "ArticleIdList": ["18310257"]}, {"Citation": "Zamorano Cuervo N, Grandvaux N. ACE2: evidence of role as entry receptor for SARS\u2010CoV\u20102 and implications in comorbidities. Elife. 2020;9:e61390.", "ArticleIdList": ["PMC7652413", "33164751"]}, {"Citation": "W\u00f6sten\u2010van Asperen RM, Bos AP, Bem RA, et al. Imbalance between pulmonary angiotensin\u2010converting enzyme and angiotensin\u2010converting enzyme 2 activity in acute respiratory distress syndrome. Pediatr Crit Care Med. 2013;14(9):e438\u2010e441.", "ArticleIdList": ["24226567"]}, {"Citation": "Endo A. The discovery and development of HMG\u2010CoA reductase inhibitors. J Lipid Res. 1992;33(11):1569\u201082.", "ArticleIdList": ["1464741"]}, {"Citation": "Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69\u201075.", "ArticleIdList": ["PMC5904709", "29392731"]}, {"Citation": "Tikoo K, Patel G, Kumar S, et al. Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications. Biochem Pharmacol. 2015;93(3):343\u2010351.", "ArticleIdList": ["25482567"]}, {"Citation": "Golomb BA, Evans MA. Statin adverse effects. Am J Cardiovasc Drugs. 2008;8(6):373\u2010418.", "ArticleIdList": ["PMC2849981", "19159124"]}, {"Citation": "Dashti\u2010Khavidaki S, Khalili H. Considerations for statin therapy in patients with COVID\u201019. Pharmacotherapy. 2020;40(5):484\u2010486.", "ArticleIdList": ["PMC7262253", "32267560"]}, {"Citation": "Dastan F, Salamzadeh J, Saffaei A, Nabavi Y, Abbasinazari M. Atorvastatin\u2010induced myalgia in Iranian patients: a hospital\u2010based study to determine the prevalence and associated risk factors. J Pharm Care. 2020;8:4."}, {"Citation": "Guan W\u2010j, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u20101720.", "ArticleIdList": ["PMC7092819", "32109013"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "4"}, {"Year": "2021", "Month": "12", "Day": "4"}, {"Year": "2022", "Month": "3", "Day": "9"}, {"Year": "2022", "Month": "3", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "5", "Minute": "42"}, {"Year": "2022", "Month": "3", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35274326", "PMC9088596", "10.1002/jmv.27710"]}}], "PubmedBookArticle": []}